Safety and tolerability of tedizolid as oral treatment for bone and joint infections

By sjmartinez • September 27, 2023

Miller LG, Flores EA, Launer B, Lee P, Kalkat P, Derrah K, Agrawal S, Schwartz M, Steele G, Kim T, Kuvhenguhwa MS. Safety and tolerability of tedizolid as oral treatment for bone and joint infections. Microbiol Spectr. 2023 Sep 26:e0128223. doi: 10.1128/spectrum.01282-23. Epub ahead of print. PMID: 37750695.

Tags: bone and joint infection, Gram-positive bacteria, Infectious Diseases, Publications, tedizolid

High rate of uncontrolled hypertension among adults receiving integrated HIV and hypertension care with aligned multi-month dispensing in Malawi: results from a cross-sectional survey and retrospective chart review

Whitehead HS, Phiri K, Kalande P, van Oosterhout JJ, Talama G, Phiri S, Moucheraud C, Moses A, Hoffman RM. High rate of uncontrolled hypertension among[...]

Brief Report: Low-Dose Methotrexate Does Not Affect Measures of HIV-1 Persistence in Individuals With Chronically Treated HIV-1 Infection

Cyktor JC, Yeh E, Ribaudo H, Hoeth D, Naqvi A, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Tawakol A, Lederman MM, Stein[...]

Sulfated glycosaminoglycans are host epithelial cell targets of the Candida albicans toxin candidalysin

Lin J, Miao J, Schaefer KG, Russell CM, Pyron RJ, Zhang F, Phan QT, Solis NV, Liu H, Tashiro M, Dordick JS, Linhardt RJ, Yeaman[...]